TCRX Total Utang marang Modal TScan Therapeutics

TCRX (TScan Therapeutics) - tandha merek perusahaan

This chart illustrating the total debt-to-equity ratio for TScan Therapeutics (TCRX) stands at 1.23. The company's financial stability is supported by grants, which offsets the impact of market volatility on trial timelines. The business relies on the T-Scan platform to develop personalized therapies, leveraging absolute demand inelasticity. Additionally, TScan Therapeutics (TCRX) is developing partnerships to identify specific tumor targets that enhance the body's immune response.

Rasio Utang marang Ekuitas: TScan Therapeutics Inc (TCRX) kanggo 04.07.2022 - 29.10.2026

Rincian metrik komprehensif lan analitis TScan Therapeutics, Inc. (TCRX)

- rega lan prakiraan konsensus rega:
Rega saham TScan Therapeutics Inc|TCRX - Target konsensus
- data kapitalisasi pasar:
Kapitalisasi pasar TScan Therapeutics|TCRX - Nilai Perusahaan
- data kapitalisasi buku:
Aset Bersih saben Siji Saham TScan Therapeutics|TCRX - Kapitalisasi Akuntansi|Rasio Kapitalisasi Pasar marang Nilai Buku tscan.com|TCRX - Gunggung Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal TScan Therapeutics|TCRX - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang ekuitas TScan Therapeutics Inc|TCRX - Kewajiban utang agregat|Utang marang nilai buku TScan Therapeutics|TCRX - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan TScan Therapeutics
Analisis komprehensif perusahaan:TCRX - TScan Therapeutics
Sampel barang TScan Therapeutics Inc

The total debt-to-equity ratio measures a business's reliance on external borrowings relative to its own funds, allowing for an assessment of financial stability and bankruptcy risk during market volatility. By analyzing the shifting proportion of total debt to equity, one can understand how TScan Therapeutics (TCRX) finances its high-tech infrastructure in Massachusetts, which confirms the fundamental reliability and autonomy of the company's operational processes.

Pesaing utama

Total Utang marang Modal ONC|Rasio Total Utang marang Ekuitas Halozyme Therapeutics, Inc.|Total Utang marang Modal RVMD|Total Utang marang Modal AAPG (Ascentage Pharma Corp)|CGON - Utang marang Ekuitas|Rasio Utang marang Ekuitas urogen.com URGN|BCAX: Total Utang marang Modal|PSNL - Rasio Total Utang marang Ekuitas|Total Utang marang Modal ERAS|DCTH (Delcath Corp) - Utang marang Modal|YMAB - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi aurabiosciences.com (AURA)|Candel Therapeutics (CADL) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Accuray Inc (ARAY)|SELLAS Life Sciences Group - Total Utang marang Modal|ACTU - Rasio Total Utang marang Ekuitas|Citius Oncology, Inc. - Rasio Total Utang marang Ekuitas|HURA: Total Utang marang Modal|Utang marang Ekuitas Protara Therapeutics, Inc. TARA|Fate Therapeutics Inc (FATE) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal WHWK (Aadi Bioscience, Inc.)|Utang marang Modal Champions Oncology Corp (CSBR)|Rasio Total Utang marang Ekuitas XBiotech Inc.|Utang Agregat marang Modal CVM (cel-sci.com)|Utang marang Ekuitas OSTX|Koefisien Total Utang marang Modal radiopharmtheranostics.com RADX|ARTV: Total Utang marang Modal|ANL - Rasio Total Utang marang Ekuitas|VERU: Total Utang marang Modal|TPST (tempesttx.com) - Total Utang marang Modal|Utang marang Ekuitas Xilio Therapeutics Inc (XLO)|Rasio Utang marang Ekuitas Enochian BioSciences (RENB)|Mural Oncology plc (MURA) - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi kairospharma.com KAPA|Rasio Total Utang marang Ekuitas OnKure Therapeutics (OKUR)|Utang Agregat marang Modal CytoMed Therapeutics Ltd GDTC|Total Utang marang Modal Curis Corp (CRIS)|APLM - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal THAR|ADVB (Advanced Biomed) - Utang marang Modal|GNPX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Calidi Bio|Total Utang marang Modal SBFM|Total Utang marang Modal XBIO (xeneticbio.com)|Salarius (SLRX) - Utang marang Ekuitas|Utang Agregat marang Ekuitas Kitov Pharma PPBT|AONC (AON) - Total Utang marang Modal|beigene.com (BGNE) - Utang marang Modal|CKPT: Rasio Total Utang marang Ekuitas|Total Utang marang Modal elevationoncology.com|iCAD Inc. (ICAD) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal Ikena|NTBL (Notable Labs, Ltd.) - Total Utang marang Modal|Koefisien Total Utang marang Modal viracta.com (VIRX)|MorphoSys - Total Utang marang Modal|NAYA Biosciences Inc - Rasio Total Utang marang Ekuitas|Utang marang Ekuitas AAPGV (Ascentage Pharma Group Ltd)